Rethinking pharma field force efficiency in developing countries
Express Pharma
|July 2025
In developing markets like India, where medical representatives remain the cornerstone of pharma sales, field force inefficiency is an expensive blind spot. Mayuresh Satpute, Partner at Vector Consulting Group, outlines how a shift from rigid Monthly Tour Plans to dynamic Flexible Journey Plans can unlock significant gains in coverage, compliance, and market share
The global pharma industry thrives on high profit margins, allowing companies to invest heavily in product promotion among healthcare professionals to generate sales. In developing markets, this effort is led by a vast network of Medical Representatives (MRS) who engage directly with doctors to drive prescriptions. In India alone, over 600,000 MRs operate nationwide, with top firms employing over 10,000 MRs each.
Pharma companies often rely on such a large sales force, expecting better doctor coverage, greater brand visibility, and increased sales. While this approach can yield initial gains, its impact diminishes over time as inefficiencies emerge. Sales teams typically operate at only 60-70 per cent efficiency due to poor planning and limited engagement with high-priority doctors. Visit frequency compliance is as low as 30-40 per cent, resulting in suboptimal doctor coverage and weakening the effectiveness of the manpower investment.
To address this, firms invest in digital solutions like CRM systems, automated reporting, and performance monitoring. However, these tools often fail to deliver their core objective: timely, productive, and targeted doctor interactions across regions. With lost sales reaching significant levels, firms are compelled to keep investing in their field force, finding themselves in a dilemma, whether to expand the sales force or run digital initiatives to improve efficiency.
This article examines how pharma companies can improve their field force's potential by addressing operational inefficiencies.
Key hurdles in the pharma field force productivity Denne historien er fra July 2025-utgaven av Express Pharma.
Abonner på Magzter GOLD for å få tilgang til tusenvis av kuraterte premiumhistorier og over 9000 magasiner og aviser.
Allerede abonnent? Logg på
FLERE HISTORIER FRA Express Pharma
Express Pharma
The invisible threat: Why packaging inks are the next major recall risk for pharma
Jatin Takkar, Head - Product Safety & Regulatory, Siegwerk India writes that packaging is emerging as a potential source of contamination due to unsafe ink chemistries. With global standards evolving, the industry must shift from reactive compliance to a proactive 'Safe by Design' approach that ensures packaging inks are as safe as the medicines they guard
4 mins
December 2025
Express Pharma
Beyond the machine: How intelligent packaging design elevates parenteral delivery
For sensitive parenteral products, the packaging is as critical as the drug itself. Uhlmann demonstrates how deep design competence turns packaging challenges into patient-centric solutions
2 mins
December 2025
Express Pharma
Ensuring Clean Room Integrity with Prime Clean Reset High-Speed Doors: Minimizing Air Permeability and Leakages
High-speed doors for clean rooms are specialized industrial doors essential for maintaining controlled environments.
3 mins
December 2025
Express Pharma
JULABO introduces Green Edition Refrigerated Circulators using natural refrigerants for sustainable lab cooling
JULABO launches its Green Edition range of refrigerated circulators designed to support laboratories in reducing carbon emissions, improving energy efficiency, and aligning with global environmental regulations
2 mins
December 2025
Express Pharma
Flexotherm Heating Tapes & Cords
Tempo's Flexotherm heating tapes and cords provide a safe, flexible, and efficient solution for maintaining solvent temperature across a wide range of industrial processes
1 mins
December 2025
Express Pharma
PRUV® -The original Sodium Stearyl Fumarate
JRS Pharma's PRUV® is the original sodium stearyl fumarate (SSF) introduced in the market over 20 years ago
5 mins
December 2025
Express Pharma
We continue to invest heavily in quality, regulatory compliance, and modernisation
Rishad Dadachanji, MD, Kaisha Packaging shares insights on emerging industry trends, new technologies showcased at CPhI & P-MEC, and how the Dadachanji Group is strengthening its integrated ecosystem to serve both domestic and global pharma markets
3 mins
December 2025
Express Pharma
Romaco begins local format part production in India
The Noack N 950E blister packaging machine with Indian-produced format parts to debut at CPHI & PMEC India 2025, followed by installation at the Romaco India Experience Centre in Hyderabad
4 mins
December 2025
Express Pharma
We built our business by obsessing over excipients
Shivang Zaveri, Director, Transchem Corporation Pharma; discusses Transchem's approach to excipients, innovation, and market strategy with Express Pharma.
2 mins
December 2025
Express Pharma
India is a cornerstone of Fette Compacting's global strategy
Ashok Gourish, Managing Director, Fette Compacting India, discusses India's pivotal role in the company's global growth, backed by expanded services, digital transformation support, and a strengthened Competence Center in Goa, in conversation with Express Pharma
5 mins
December 2025
Listen
Translate
Change font size

